Patent ID: 11945822
Assignee: LEAD DISCOVERY CENTER GMBH
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 9:
10. The compound according to claim 1, having the general formula IX, wherein X is N; L1, R2, R6, R22, R24 and R25 are as defined in claim 1, and X3 is, independently at each occurrence, selected from CR10 and N;
R23 is selected from the group consisting of hydrogen, halogen, C1-C3 haloalkyl, —OR5, —CN and C1-C6 alkyl optionally substituted with —OH, or —OR5;
wherein Q2 is any structure of the following group F;, R31 and R32 are either absent or independently, at each occurrence, selected from the group consisting of hydrogen, —OR5, halogen, —N(R5)R5, —NR9R12, —NH(C═O)R5, —(C═O)NH2, aryl, heteroaryl, heterocyclyl, C1-C6 alkyl and C1-C6 alkyl substituted with —OH or —NH2; and
wherein R5, R9 and R12 are as defined in claim 1.